PHG 537 - Pharmacoeconomics, Genetics, and Healthcare

Alternate Course Number 

This class is ‘withered’ (taught along with) PHARM534/HSERV583, which covers the same material but requires a research project.
References to the course project below do not apply to students taking PHG537. However, PHG537 students are expected to attend all presentations of the projects, and fully participate in discussion of them.

Course Description 

This is an introductory course in economic evaluation in healthcare offered jointly by the School of Pharmacy’s Pharmaceutical Outcomes Research and Policy Program (https://sop.washington.edu/department-of-pharmacy/pharmaceutical-outcomes-research-policy-program-porpp/(link is external)) and the School of Public Health’s Institute for Public Health Genetics (http://depts.washington.edu/phgen/(link is external)).  Attention is focused on cost-effectiveness and cost-benefit analysis, measures of health-related quality of life, technology assessment, resource allocation, pharmacoeconomics, and medical decision-making. We will also cover issues related to genomics, including cost-effectiveness of genetic testing and screening, and insurance and employment issues related to genetic information. 

Course Objectives 

After this course, the student will be able to:

  • Compare and contrast the different methods for economic evaluation in health care;
  • Describe the instruments for measuring health state preferences;
  • Evaluate a simple decision analysis model;
  • Identify the role of economic evaluation in decision making and health policy;
  • Critically evaluate a published cost-effectiveness study;
  • Apply economic evaluation and health technology assessment to genetic tests

 

Example Syllabus